Sarepta Therapeutics target price cut to $20 from $23 by JPMorgan
SRPT•JPMorgan cut its target price for Sarepta Therapeutics to $20 from $23.
Related News
KKR sells CTT's Japan and Korea businesses to institutional investors
KKR•
Japan August factory output unexpectedly falls
EWJ•
Fortune Brands Innovations EVP, CFO Peter G. Clifford files initial beneficial ownership statement
FBIN•
Apollo funds complete acquisition of Nippon Sheet Glass
APO•
China's AI agents can lie and scheme, just like their US rivals
QQQ•